Serum complement factor I is associated with disease activity of systemic lupus erythematosus.

MLA

Tseng, Min-Hua, et al. “Serum Complement Factor I Is Associated with Disease Activity of Systemic Lupus Erythematosus.” Oncotarget, vol. 9, no. 9, Jan. 2018, pp. 8502–11. EBSCOhost, https://doi.org/10.18632/oncotarget.23907.

APA

Tseng, M.-H., Lin, S.-H., Wu, C.-Y., Chien, H.-P., Yang, H.-Y., Chen, Y.-C., Chou, Y.-C., & Huang, J.-L. (2018). Serum complement factor I is associated with disease activity of systemic lupus erythematosus. Oncotarget, 9(9), 8502–8511. https://doi.org/10.18632/oncotarget.23907

Chicago

Tseng, Min-Hua, Shih-Hua Lin, Chao-Yi Wu, Hui-Ping Chien, Huang-Yu Yang, Yung-Chang Chen, Yu-Ching Chou, and Jing-Long Huang. 2018. “Serum Complement Factor I Is Associated with Disease Activity of Systemic Lupus Erythematosus.” Oncotarget 9 (9): 8502–11. doi:10.18632/oncotarget.23907.